Muthusamy Jayaraman
65Patents
19h-index
57Co-inventors
87Inventor score
Filing activity: Jul 20, 2001 → Mar 4, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8158601B2 | Lipid formulation | Emerging Cross-Sectional Technologies | 293 | Active |
| US9345780B2 | Site specific delivery of nucleic acids by combining targeting ligands with endosomolytic components | Chemistry; Metallurgy | 237 | Active |
| US8642076B2 | Lipid containing formulations | Human Necessities | 138 | Active |
| US8802644B2 | Lipid formulation | Emerging Cross-Sectional Technologies | 110 | Active |
| US9394234B2 | Lipid formulations | Emerging Cross-Sectional Technologies | 99 | Active |
| US8883202B2 | Lipid compositions | Emerging Cross-Sectional Technologies | 95 | Active |
| US9012498B2 | Biodegradable lipids for the delivery of active agents | Chemistry; Metallurgy | 94 | Active |
| US8999351B2 | Lipids and compositions for the delivery of therapeutics | Emerging Cross-Sectional Technologies | 91 | Active |
| US9186325B2 | Lipids and compositions for the delivery of therapeutics | Emerging Cross-Sectional Technologies | 89 | Active |
| US8575123B2 | Site-specific delivery of nucleic acids by combining targeting ligands with endosomolytic components | Chemistry; Metallurgy | 52 | Active |
| US8722082B2 | Lipids and compositions for the delivery of therapeutics | Chemistry; Metallurgy | 37 | Active |
| US9682922B2 | Biodegradable lipids for the delivery of active agents | Chemistry; Metallurgy | 36 | Active |
| US6509344B1 | Indenoisoquinolines as antineoplastic agents | Human Necessities | 33 | Expired |
| US9682139B2 | Lipids and compositions for the delivery of therapeutics | Emerging Cross-Sectional Technologies | 28 | Active |
| US9061063B2 | Biodegradable lipids for the delivery of active agents | Chemistry; Metallurgy | 27 | Active |
| US9220683B2 | Lipids and compositions for the delivery of therapeutics | Emerging Cross-Sectional Technologies | 23 | Active |
| US8507455B2 | Folate conjugates | Human Necessities | 22 | Active |
| US8962580B2 | Chemical modifications of monomers and oligonucleotides with cycloaddition | Emerging Cross-Sectional Technologies | 22 | Active |
| US10369226B2 | Biodegradable lipids for the delivery of active agents | Chemistry; Metallurgy | 19 | Active |
| US11246933B1 | Biodegradable lipids for the delivery of active agents | Chemistry; Metallurgy | 14 | Active |
| US9687550B2 | Compositions for nucleic acid delivery | Chemistry; Metallurgy | 12 | Active |
| US11504391B1 | Modified RNA agents with reduced off-target effect | Chemistry; Metallurgy | 12 | Active |
| US9999673B2 | PEGylated lipids and their use for drug delivery | Chemistry; Metallurgy | 11 | Active |
| US10117941B2 | Lipids and compositions for the delivery of therapeutics | Emerging Cross-Sectional Technologies | 10 | Active |
| US11382979B2 | Biodegradable lipids for the delivery of active agents | Chemistry; Metallurgy | 9 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.